Prevalence and distribution of hepatitis C subtypes in patients with opioid dependence

European Addiction Research

Volumn 6, Issue 4, 2000, Pages 198-204

  Gombas, Wolfgang ^a,c   Fischer, Gabriele ^a   Jagsch, Reinhold ^a   Eder, Harald ^a   Okamoto, Ichiro ^a   Schindler, Shird ^a   Müller, Christian ^b   Ferenci, Peter ^b   Kasper, Siegfried ^a  

^a Department of General Psychiatry

^b Clinical Department of Gastro Enterology and Hepatology   (Austria)

^c NONE   (Austria)

Author keywords

Drug addiction; Hepatitis B; Hepatitis C; Human immunodeficiency virus

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; OPIATE; VIRUS RNA;

ADOLESCENT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CHRONIC DISEASE; COMORBIDITY; DRUG DEPENDENCE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; VIRUS CLASSIFICATION; VIRUS INFECTION;

ADOLESCENT; ADULT; AUSTRIA; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS C; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0034532219     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052046     Document Type: Article

References (45)

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
2. Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups
3. Hepatitis C virus infection in spouses of patients with type C chronic liver disease
4. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 4, 5a, 6a
5. Prevalence of the genotypes of the hepatitis C virus in Spanish drug addicts with chronic hepatitis C
6. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study
7. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: A comparison between immunocompetent and immunocompromised patients
8. Treatment with interferon(s) of community-acquired chronic hepatitis cirrhosis type C
9. Hepatitis C antibody and cryoglobulins in patients with cirrhosis and hepatocellular carcinoma
10. Long-term follow-up of posttransfusion and sporadic chronic hepatitis NANB and frequency of circulating antibodies to hepatitis C virus (HCV)
11. Interrelationship of blood transfusion, non-A non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
12. Differences in the hepatitis C virus genotypes in different countries
13. Severity of liver disease with different hepatitis C viral clones
14. Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: A case-control study
15. Hepatitis C
16. Hepatitis C virus infection, cryoglobulinemia, and glomerulonephritis
17. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus
18. Rheumatologic manifestations of malignancy
19. Non-Hodgkin's lymphoma and hepatitis C virus infection
20. Risk factors for the transmission of hepatitis C
21. Mother-to-child transmission of a hepatitis C virus variant with an insertional mutation in its hypervariable region
22. Intrafamily transmission of hepatitis C virus: Sexual and non-sexual contacts
23. Virushepatitis C
24. Hepatitis C
25. Hepatitis C epidemiology in the world
26. Hepatitis C virus genotypes and severity of chronic liver disease in haemophiliacs
27. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence
28. Sexual behaviour and multiple infections in drug abusers
29. Characteristics of hepatitis C virus among intravenous drug users in Iceland
30. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin
31. Patientengefährdung durch virus-infizierte Ärzte?
32. Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon)
33. Genotyping of Canadian hepatitis C virus isolates by PCR
34. Prevalence of hepatitis C virus genotypes in Italy
35. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide
36. High prevalence of hepatitis C virus genotype 6 among certain risk groups in Hong Kong
37. Hepatitis C virus genotypes in the United States: Epidemiology, pathogenicity, and response to interferon therapy
38. Epidemiology of hepatitis C virus infection among injecting drug users in Australia
39. Hepatitis C transmission on the north coast of New South Wales: Explaining the unexplained
40. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: A pilot study
41. Dose increase augments response rate to interferon-alpha in chronic hepatitis C
42. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effect of dose and duration
43. Management of hepatitis C